Medication info
Baikojajeong (Losartan Potassium)

Baikojajeong (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Baenex Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200600128 · Notified 2006.02.28

Summary

Main use
Treatment of kidney disease in patients with hypertension or type 2 diabetes accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg orally once daily as losartan potassium. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be administered orally in 2 divided doses per day or, if necessary, increased to 100 mg once daily. 3) If blood pressure is not controlled with this drug alone, it may be coadministered with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect was observed when coadministered with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this drug once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be coadministered with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this drug once daily is recommended. 3) Patients with reduced intravascular effective circulating volume An initial dose of 25 mg of this drug once daily is recommended for patients who may have reduced intravascular effective circulating volume (e.g., patients receiving diuretic treatment) (see Precautions for Use). 4) Patients with hepatic impairment Consider administering a low dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years or older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this drug once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Baenex Co., Ltd.

Efficacy & effects

Treatment of kidney disease in patients with hypertension or type 2 diabetes accompanied by hypertension

  • Hypertension
  • kidney disease in type 2 diabetes patients
View approved original text

This medication is used to treat hypertension. It is particularly helpful in preventing and treating kidney disease in patients with type 2 diabetes accompanied by hypertension. Therefore, it is actively used for managing complications related to hypertension.

How to take

Adult dose

This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg orally once daily as losartan potassium. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be administered orally in 2 divided doses per day or, if necessary, increased to 100 mg once daily. 3) If blood pressure is not controlled with this drug alone, it may be coadministered with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect was observed when coadministered with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this drug once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be coadministered with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this drug once daily is recommended. 3) Patients with reduced intravascular effective circulating volume An initial dose of 25 mg of this drug once daily is recommended for patients who may have reduced intravascular effective circulating volume (e.g., patients receiving diuretic treatment) (see Precautions for Use). 4) Patients with hepatic impairment Consider administering a low dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years or older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this drug once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause serious harm to the fetus and newborn if taken by pregnant women, especially during the second and third trimesters, and should not be taken by pregnant women or women who may become pregnant. This medication should not be administered to patients with allergic reactions to it, severe liver impairment, certain genetic disorders, or specific cardiovascular diseases. Particular caution is required when this medication is used in the elderly, patients with reduced kidney function, or those with high potassium levels, and regular monitoring is necessary to ensure blood pressure does not drop too low. This medication can cause side effects such as muscle pain, dizziness, cough, and dyspepsia, and there is a rare risk of severe allergic reactions, liver dysfunction, or kidney failure. Any unusual symptoms should be immediately discussed with a healthcare professional. Interactions may occur if taken with other antihypertensive medications, potassium supplements, or certain diuretics, so consultation with a doctor or pharmacist before use is essential. It is advisable for pregnant or breastfeeding women not to take this medication; if it is unavoidable, they should consult with a healthcare professional for appropriate measures. This medication should not be administered to children, especially those under the age of 6, and should be given cautiously to the elderly. In case of overdose, symptoms such as hypotension or bradycardia may occur, necessitating immediate treatment. This medication is not removed by blood dialysis, so appropriate measures should be taken according to the instructions of healthcare professionals. During the course of taking this medication, if pregnancy is planned or confirmed, immediate consultation with a healthcare professional is necessary, and potassium supplements or potassium-containing salt substitutes should not be taken without consulting a doctor. Keep this medication out of reach of children and do not transfer it to another container.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • muscle spasm
  • lumbago
  • leg pain
  • dizziness
  • congestion
  • upper respiratory tract infection
Show 132 more
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness/fatigue
  • edema/swelling
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm desquamation
  • hemolysis
  • facial edema
  • fever
  • orthostatic effect
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory impairment
  • decreased libido
  • memory disturbances
  • migraine
  • neuroirritability
  • paresthesia
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • purpura
  • erythema
  • flushing
  • photosensitivity reaction
  • pruritus
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning and pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • visual impairment
  • erectile dysfunction
  • nocturia
  • polyuria
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • abnormal liver function
  • hepatitis
  • intestinal vascular edema
  • malaise
  • thrombocytopenia
  • myalgia
  • weakness
  • creatine kinase elevation
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • ALT elevation
  • BUN increase
  • serum creatinine increase
  • hemoglobin decrease
  • hematocrit decrease
  • liver enzyme elevation
  • serum bilirubin increase
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beat
  • atrial fibrillation
  • hypoglycemia
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.